Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Men who carry mutations in BRCA1 or BRCA2 are at increased risk for prostate cancer. However the efficacy of prostate screening in this setting is uncertain and limited data exists on the uptake of prostate screening by mutation carriers. This study prospectively evaluated uptake of prostate cancer...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: McKinley, Joanne M, Weideman, Prue C, Jenkins, Mark A, Friedlander, Michael L, Hopper, John L, McLachlan, Sue-Anne, Lindeman, Geoffrey J, Investigators, kConFab, Phillips, Kelly-Anne
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2007
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736989/
https://ncbi.nlm.nih.gov/pubmed/19725993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-5-3-161
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak